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 Polymeric micro- and nanopartides are becoming a mainstay in
 biomedicine, medical diagnostics, and therapeutics, where they
 are used in implementing sensing mechanisms, as imaging con-
 trast agents, and in drug delivery. Current approaches to the fab-
 rication of such particles are typically finely tuned to specific
 monomer or polymer species, size ranges, and structures. We pres-
 ent a general scalable methodology for fabricating uniformly sized
 spherical polymeric particles from a wide range of polymers pro-
 duced with complex internal architectures and continuously tun-
 able diameters extending from the millimeter scale down to
 50 nm. Controllable access to such a wide range of sizes enables
 broad applications in cancer treatment immunology, and vaccines.
 Our approach harnesses thermally induced, predictable fluid insta-
 bilities in composite core/cladding polymer fibers drawn from
 a macroscopic scaled-up model called a "preform." Through a
 stack-and-draw process, we produce fibers containing a multiplic-
 ity of identical cylindrical cores made of the polymers of choice
 embedded in a polymer cladding. The instability leads to the
 breakup of the initially intact cores, independent of the polymer
 chemistry, into necklaces of spherical particles held in isolation
 within the cladding matrix along the entire fiber length. We dem-
 onstrate here surface functionalization of the extracted particles
 for biodetection through specific protein-protein interactions, vol-
 umetric encapsulation of a biomaterial in spherical polymeric
 shells, and the combination of both surface and volumetric func-
 tionalities in the same particle. These particles used in distinct
 modalities may be produced from the desired biocompatible poly-
 mer by changing only the geometry of the macroscopic preform
 from which the fiber is drawn.
 Medical drug delivery applications (4) typically in diagnostics make use (1), of imaging micro- (2, and 3), nano- and drug delivery (4) typically make use of m cro- and nano-
 partides in two distinct modes: The surfaces may serve as loci for
 chemical or biological interactions through surface functionali-
 zation (5), or, alternatively, the volume may be used to carry
 cargo (6, 7) for drug delivery and multidimensional imaging
 modalities (8). Polymeric nanopartides in particular are steadily
 gaining importance in medicine because of their long half-life in
 the blood stream (9, 10) and the versatility by which their compo-
 sition, size, shape, and physicochemical properties (11) may
 be tuned via a variety of processing approaches. Recent medical
 achievements based on the use of polymer particles in specific
 applications include the targeted delivery of drugs and toxins using
 surface-conjugated biodegradable polymer particles (12, 13), treat-
 ment of antibiotic-resistant bacterial infections (14, 15), and in-
 duction of regulatory T cells for treatment of multiple sclerosis (16).
 Current bottom-up synthetic approaches produce nanoparti-
 des that typically have considerable size dispersion, cannot reach
 the microscale, and are sensitively tuned to specific chemical
 building blocks (17). Top-down processes, on the other hand,
 such as emulsification (18), the use of templates (19), and
 microfluidics-based approaches (20-25), exploit polymers in a low-
 viscosity state or in solution and rely on prefabricated devices to
 impart form and size to the particles, which are subsequently
 solidified. In general, the process kinetics in both strategies,
 bottom-up and top-down, limit each approach to a narrow set
 of materials, sizes, and structures. Individualized biomedical
 applications require varying particle sizes and modalities, which,
 in turn, necessitate different materials-specific fabrication path-
 ways for producing such diverse structures. For example, no
 single nanoparticle size can reach the different areas of a tumor
 and the surrounding stroma (26, 27), and particle size was found
 to be crucial in cell adsorption and internalization (28). These
 findings suggest the benefit of particle fabrication processes that
 are not constrained to narrow size spans. The widespread
 adoption of polymeric particles in current and future biomedical
 applications would be enhanced by addressing the challenge of
 developing a scalable process that is sufficiently versatile to
 bridge the micro- and nanoscales, is compatible with a variety of
 polymers, and is capable of producing a multiplicity of particle
 architectures optimized for specific applications.
 Here, we describe a scalable top-down process that yields
 uniformly sized spherical polymer particles with continuously
 tunable diameters from micro- to nanoscales realized in pre-
 scribed structures without recourse to any premade device in
 which the particles are formed. In lieu of prefabricated templates
 (19) or microfluidic channels filled with coflowing fluids (25), we
 rely here on thermal treatment of a core/cladding polymer fiber
 to fluidize the core and controllably induce at the interfaces the
 Plateau-Rayleigh capillary instability (PRI) (29-31), the natural
 tendency of fluid cylinders to break up into spheres. The desired
 polymer is placed in the core of a scaled-up macroscopic (centi-
 meter-scale) "preform" in the solid state, which is then thermally
 drawn into an extended fiber that defines the initial conditions
 for the process (32, 33). The PRI results in an initially intact
 cylindrical core breaking up into a necklace of uniformly sized
 spherical particles held stationary in isolation following quenching
 Significance
 A scalable, chemistry-independent, fluid-instability-mediated
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 in the solid cladding matrix along the whole fiber length, to be
 released when needed using an appropriate solvent (34, 35).
 Complex particle architectures are achieved by judicious design
 of the core geometry at the macroscopic preform stage, which is,
 in turn, inherited by the resulting particles. The scalability of the
 process stems from stacking a high density of cores inside a single
 fiber produced rapidly with extended lengths using the traditional
 process of thermal drawing. Furthermore, we confirm that the
 PRI-based process is "chemistry-independent" by using it to
 produce particles from different polymers, some of which have
 not been used heretofore in particle form despite their useful
 biochemical, mechanical, and optical properties. Such salutary
 features combined in this in-fiber fabrication approach (i.e., size
 control, scalability, compositional, structural control) may enable
 such polymeric particles to play an important role in biomedical
 applications, such as recognition of specific cell types through
 protein binding (36), separation of specific cells from a mixture
 (37), and delivering biological materials or drugs (38). The large
 quantities of particles produced may enable applications in
 cosmetics (39) and emulsions used in coatings and paints,
 whereas the size uniformity of polymeric particles is crucial in
 ultrasound imaging (40). We establish critical steps toward
 achieving these goals via three key demonstrations of biomedical
 importance: (a) protein binding to the particle surfaces for bio-
 sensing, (b) quantitative control over differential surface protein
 binding, and (c) encapsulation of a biological material in
 a polymeric shell using collagen as a model material. These
 demonstrations are carried out using the same biocompatible
 polymer in two different particle structures, a solid spherical
 particle for surface functionalization and a hollow spherical
 particle for volumetric cargo encapsulation, produced by the in-
 fiber fabrication methodology. We also confirm that both surface
 and volume functionalities may be combined in the same parti-
 cle, a result that has wide implications for site-specific drug de-
 livery (41).
 Results
 The in-fiber particle fabrication procedure may be divided into
 three stages (35) (Fig. 'A)'(i) macroscopic preform preparation
 (stage I), (//) thermal fiber drawing (stage II), and (Hi) thermally
 induced in-fiber emulsification via the PRI (stage III). The
 structure of the particle is determined in the preform fabrication
 stage, whereas its size, proportional to the fiber core diameter, is
 set in the fiber-drawing stage. The three processing stages are
 illustrated in Fig. L4, where a preform consisting of a 700-jim-
 diameter cylindrical cyclic olefin polymer (COP) (42) core sur-
 rounded by a 35-mm-diameter polysulfone (PSU) cladding
 (stage I) is thermally drawn into hundreds of meters of a uniform
 1-mm-diameter fiber with a 20-nm-diameter core (stage II; Fig.
 IB). The drawn fiber is thermally treated under ambient
 conditions, thereby reducing materials viscosity and inducing
 the PRI (stage III), whose dynamics are shown in Fig. 1 C. The
 process is seeded by thermodynamic fluctuations that arise at the
 core/cladding interface upon heating. The classic Tomotika
 model of the PRI predicts that the fluctuation wavelength with
 the shortest growth time dominates and its amplitude increases
 without bound (34, 43), leading to the breakup of the COP core
 into a necklace of uniformly sized spherical particles held in the
 PSU cladding. The breakup wavelength is determined by the
 core diameter, interface surface energy, and materials viscosities
 (34). The diameter of the produced particles may thus be con-
 tinuously tuned, for fixed core and cladding materials and pro-
 cessing conditions, by changing the diameter of the fiber, which
 is readily achieved by adjusting the drawing parameters. This
 unique feature appropriated from the process of fiber drawing
 allows for particle size tuning over several orders of magnitude in
 linear dimension (35, 44-46). After breakup, we extract the COP
 particles by selective dissolution of the PSU cladding [using
 Fig. 1. In-fiber emulsification as a route to producing spherical polymer
 particles. (A) Preform-to-fiber approach. A centimeter-scale preform ( Upper
 Leň) is drawn into a 1-mm-diameter fiber. The Roman numerals identify the
 three fabrication stages outlined in the main text. (B) Optical transmission
 micrograph of the fiber cross-section consisting of a 20-^m-diameter COP
 core inside a PSU cladding. (C) Side views of a section of a fiber undergoing
 thermal treatment at 321 °C showing the temporal evolution of the PRI
 starting from the intact cylindrical COP core until it breaks up into a necklace
 of particles embedded in the PSU cladding. (D) Size tunability of COP par-
 ticles, released from the PSU cladding using DMAC, demonstrated in scan-
 ning electron micrographs. [Scale bar: D, successively reduced by a factor of
 5 ( Upper to Lower)]. Particle diameters are ~53 nm, 10.6 ^m, 2.2 ^irn, 270 nm,
 and 61 nm. Details of the fabrication process are provided in Supporting
 Information.
 dimethylacetamide (DMAC)]. Note that the dissolved cladding
 polymer may be recycled from the solution and reused as a
 cladding for a new fiber. In Fig. ID, we show scanning electron
 micrographs of representative examples of particles with diam-
 eters extending three orders of magnitude from ~50 'im down to
 ~50 nm. In general, this process yields a particle size distribution
 having ~10% SD normalized with respect to the mean particle
 size (details are provided in ref. 35).
 The scalability of particle production may be enhanced by
 incorporating a large number of identical cores into the preform.
 Two examples are shown in Fig. 2 to highlight this unique fea-
 ture: a 14-core fiber (each with a 20-|im diameter; Fig. 2 A-D)
 and a 1,000-core fiber (each with a 500-nm diameter; Fig. 2 E-
 G), with both having a 1-mm o.d. Thermal treatment of either
 fiber leads to the simultaneous breakup of all the cores via the
 PRI into a 3D arrangement of particles held stationary in the
 cladding matrix. The limit on the particle production rate is thus
 set by the fiber-drawing speed, the fiber o.d., and the fiber-filling
 ratio (percentage of the fiber transverse cross-section occupied
 by the cores). Using currently available fiber fabrication tech-
 nology, our process may yield on the order of a few kilograms of
 structured polymeric particles per day independent of the par-
 ticle size or structure.
 Our approach relies on placing the desired polymer in the core
 within a sacrificial thermoplastic polymer cladding chosen such
 15550 I www.pnas.org/cgi/doi/10.1073/pnas.1310214110 Kaufman et al.
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 Fig. 2. Scalable in-fiber emulsification. Microscale (A~D ) and nanoscale ( E-G )
 in-fiber emulsification. (A) Optical transmission micrograph of the cross-
 section of a 14-core fiber with 20-nm-diameter COP cores in a PSU cladding.
 (Inset) Individual core cross-section. ( B ) Scanning electron micrograph of the
 fiber side view showing the 14 intact COP cores after dissolving the PSU
 cladding. The cores coalesce after removing the fiber from the solvent. (C)
 Optical transmission micrograph of the fiber side view after thermally in-
 ducing the PRI, resulting in the cores breaking up into spherical particles
 held stationary in the cladding matrix. (D) Optical transmission micrograph
 of the released COP particles after dissolving the PSU cladding. ( E and F)
 Scanning electron micrographs of 1,000 intact 500-nm-diameter COP cores
 emerging from the fiber after dissolving the PSU cladding matrix. (G)
 Scanning electron micrograph of the released COP particles. (Inset) Scanning
 electron micrograph of a single particle. (Scale bar: 500 nm.)
 that the pair of polymers may be thermally codrawn (32, 33). A
 unique aspect of this physical process is that it depends on the
 rheology of the materials and not on their chemistry, as long as
 they are immiscible. This was confirmed by producing particles
 from a wide range of polymers, including polystyrene (PS),
 polycarbonate (PC), acrylonitrile butadiene styrene (ABS), poly-
 etherimide (PEI), and polyethersulfone (PES) {Supporting In-
 formation). These polymers have very different biochemical,
 mechanical, and optical characteristics, and some of them (e.g.,
 COP and ABS) have yet to be produced in particle form. For
 example, ABS at room temperature is a rigid polymer, but its
 characteristics at room temperature do not come into play dur-
 ing breakup under thermal treatment. Although PS is extensively
 used in biomedicine due to its low density (allowing for sus-
 pension of PS particles in aqueous solutions) and its chemical
 inertness, COP maintains these characteristics with the addi-
 tional benefits of its excellent protein adsorption characteristics
 (47) and resistance to many more chemicals than PS, such as
 acids, alkalis, and most organic polar solvents (e.g., acetone,
 methanol, isopropyl alcohol) (48). Furthermore, the in-fiber
 process allows for combining inorganic glasses and polymers in
 a single-particle geometry (35).
 Thus, although the particle formation process itself is in-
 dependent of the chemistry of the core and cladding materials,
 extracting the particles by selective dissolution of the cladding,
 on the other hand, does indeed depend on the chemistry of the
 fiber materials, which places restrictions on the potential poly-
 meric core/cladding pairings. This constraint is lifted by separating
 the core and cladding polymers with a thermally compatible in-
 organic buffer layer added in the preform, in which case the core
 and cladding may even be the same polymer. We realize this de-
 sign here using PES in both the core and the cladding separated by
 a layer of the thermally compatible chalcogenide glass, As2Se3
 (49) (Fig. 3 B and C and Supporting Information). The PRI yields
 particles having a core (polymer)/shell (glass) structure that are
 released by dissolving the polymer cladding (using DMAC), and
 the polymer particles are extracted by subsequent removal of the
 shell (using NaOH in deionized water; Fig. 3D).
 Fig. 3. Inorganic sacrificial buffer layer to facilitate particle extraction. (A)
 Schematic of the fiber structure. (B and C) Optical reflection micrographs of
 the fiber cross-section at two stages in the fabrication process (Supporting
 Information). The core consists of a PES (P) cylinder surrounded by a layer of
 an inorganic glass, As2Se3 (G). The core is embedded in a PES cladding ma-
 trix. (D) Time-lapse transmission optical micrographs of core (P)/shell (G)
 particles placed in NaOH solution. The glass shell is dissolved, leaving behind
 the polymer cores. (E) Theoretically predicted values for the figure-of-merit
 ß based upon calculated breakup wavelengths Ai and A2 assuming equal-
 amplitude perturbations (Supporting Information). Black continuous lines
 are contours of fixed ß at the values of 0.2, 0.3, and 0.4. The dashed red line
 corresponds to the experimental values of Dcore and Dshe N. Di and D2 are the
 experimental values for Dcore and Dsheii/ respectively.
 Kaufman et al. PNAS | September 24, 2013 | vol.110 | no. 39 | 15551
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 Because the PRI develops at the two cylindrical interfaces, the
 polymer-core/glass-buffer inner interface and the glass-buffer/
 polymer-cladding outer interface (Fig. 3/4), the buffer thickness
 must be chosen to ensure the formation of the core/shell struc-
 ture. The instability wavelengths at these interfaces (X' and A2,
 respectively) will generally be different. To assess whether the
 chosen physical and geometric parameters yield a core/shell
 structure, we adopt a figure-of-merit ß = AÀ/À, where AÀ = À2~ X'
 and À = Small values of ß (i.e., X'~Xi) indicate that the
 breakup produces the target core/shell geometry, whereas large
 values of ß indicate that multiple polymer cores may form within
 the glass shell. Using a recently developed theoretical model
 based on linear stability analysis of the PRI in multilayer cylin-
 drical structures (50-52), we calculate ß for different ratios of
 core and shell diameters ( Dcore and Aheib respectively) and vis-
 cosities (ßcore and /¿shell' respectively) assuming that the average
 initial perturbation amplitudes at the two interfaces are equal
 (Fig. 3 E). This model reveals a wide range of parameters that yield
 the target structure (taken to occur when ß < 0.4), including our
 case of Dsheu «2.5Dcore. These results may be generalized to sys-
 tems comprising three different fluids (50), corresponding to mul-
 tiple emulsions, a feature that we exploit below for encapsulation.
 A further degree of freedom that may be accessed by the in-
 fiber approach is the particle internal structure, which follows
 that of the constructed macroscopic preform. Along these lines,
 we have produced polymer core/shell particles (COP core and
 PC shell) and bicompartmentalized polymer Janus particles
 (PES and PEI hemispheres) (Supporting Information). Applying
 our general fabrication strategy using different preform struc-
 tures but the same biocompatible polymer (COP), we produce
 two distinct particle structures tuned to two different classes of
 applications. The first class consists of solid particles that we use
 for demonstrating surface binding of protein and fluorescent
 antibodies (FAs), a necessary step for biosensing; furthermore,
 we verify controllable protein coating of the COP particles while
 maintaining biological specificity. Using the same fabrication
 procedure applied to a hollow-core fiber design, a second class of
 particles is developed for encapsulation of selected materials in-
 side a COP shell. We demonstrate this feature using collagen as a
 model biological material, motivated by recent work demonstrating
 the utility of collagen nanoparticles in skin tissue engineering (53),
 bone regeneration (54), and treatment of bacterial infection (55).
 We first demonstrate that the surfaces of the polymer particles
 produced by the fluid instability-based process are amenable to
 protein binding without pretreatment, and are thus suitable for
 biosensing applications. By coating solid COP microparticles,
 removed from the fiber PSU cladding, with antibodies conju-
 gated with fluorophores (FAs) through adsorption, we directly
 monitor optically the presence of bound proteins using two
 readily distinguishable FAs: yellow-fluorescing FAI [Cy3-conju-
 gated anti-rabbit antibodies produced in goat (gAr); Fig. 4 A] and
 red-fluorescing FA2 [Alexa Fluor-647-conjugated anti-mouse
 antibodies produced in goat (gAm); Fig. 4 B] (details are pro-
 vided in Supporting Information). We next verified that the par-
 ticle-bound proteins retain their native conformation through
 optical detection of specific protein-protein interactions. We
 coated the particles with mouse serum proteins and monitored
 the fluorescence emitted by two FAs incubated with the particles,
 one that recognizes mouse serum proteins (FA2, gAm anti-
 bodies; Fig. AD) compared with one that does not (FAI, gAr
 antibodies; Fig. 4 C). Lack of fluorescence from FAI indicates
 that mouse serum proteins remain uniformly bound to the par-
 ticles in their native conformation, thereby preventing FAI from
 binding directly to the particles. Moreover, protein binding may
 be promoted through adding a positive charge to the hydrophobic
 polymer particle surface by coating it with poly-L-lysine, a positively
 charged synthetic amino acid chain. This enhancement was con-
 firmed by detecting stronger fluorescence from bound antibodies
 (compare the panels in Fig. 4 A and E) and also by observing
 Förster resonant energy transfer (FRET) between two tandem
 layers of particle-bound FAs (56, 57) from FAI to FA3 (Alexa
 Fluor-647-conjugated anti-goat antibodies produced in donkey).
 Antibodies F A3 recognize FAI and fluorescence from FAI
 overlaps with the FA3 excitation band, thereby allowing for
 FRET transfer (Fig. 4 E). We further verified that protein binding
 is independent of particle diameter down to 500-nm diameters by
 incubating 500-nm-diameter COP particles (Figs. 2 G and 4 F) with
 FA4 (Alexa Fluor-488-conjugated gAm antibodies).
 In addition to binding proteins uniformly to the polymer
 particles, we obtained clear evidence for quantitative control
 over the relative composition of the immobilized proteins using
 different mixtures of cofilin and BSA as examples. We confirmed
 that the relative composition of the particle-bound proteins
 matches that of the mixtures used in solution, first by dissocia-
 tion via boiling in a denaturing buffer and quantification of the
 recovered proteins by electrophoresis in SDS Polyacrylamide
 gels stained to identify BSA and cofilin. Second, we monitored
 the amount of particle-bound cofilin directly by incubation with
 specific FAs and measuring the fluorescence (Supporting In-
 formation). These results thus confirm that the particles can be
 coated with a controlled amount of a protein that can be re-
 trieved for subsequent characterization and quantification.
 Fig. 4. Quantitative assessment of preferential protein coating
 to polymer particles. (A and B) COP particles coated with FA1 (gAr)
 or FA2 (gAm) yield yellow or red fluorescence when excited at 561
 nm or 647 nm, respectively. Here, Aex is the excitation wavelength,
 Aem is the emission wavelength, and green and red arrows cor-
 respond to the excitation with Àex = 561 nm and Aex = 647 nm,
 respectively. (C and D) COP particles coated with mouse serum
 (MS) yield red fluorescence with MS-specific FA2 (gAm) and none
 with nonspecific FA1 (gAr). (E ) COP particles after treatment with
 poly-L-lysine are coated with FA1 and then FA3 [anti-goat anti-
 bodies produced in donkey (dAg), which recognize FA1]. Both
 antibodies independently produce fluorescence upon excitation.
 When FA1 is excited (at Xex = 561 nm) and the red fluorescence of
 FA3 at Aem = 675 nm is monitored, we observe evidence for FRET
 transfer from FA1 to FA3. (F, i) Differential interference contrast
 (DIC) micrograph of a COP nanopartide (diameter of ~500 nm;
 Fig. 26). FL, fluorescence. ( F , //) Native autofluorescence of the
 COP particle under short-wavelength (405 nm) excitation. (F, /'//)
 Fluorescence micrograph of the COP particle after coating with
 FA4. (F, iv) Combined DIC and fluorescence image of the FA4-
 coated COP nanopartide. (Scale bars: 500 nm.)
 15552 I www.pnas.org/cgi/doi/10.1073/pnas.1310214110 Kaufman et al.
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 Fig. 5. Microencapsulation of biological materials in polymer shells. (>4) Schematic of the steps for producing collagen-filled COP microcapsules. (Inset)
 Hollow-fiber core lined with COP after dissolving the PSU cladding at the fiber tip. Optical transmission micrograph of the side view of the fiber before ( B ) and
 after (C) being filled with collagen (slightly doped with a dye for visualization). (D) Encapsulated collagen particles (COP shell) held in the PSU cladding. (£)
 Collagen/COP microcapsules released from the cladding. (Scale bars: B-E, 200 um.) (F) Collagen recovered after dissolving the COP shell. (6) A confocal
 fluorescence micrograph of a collagen-filled microparticle with surface-bound FAs. (H) An overlay of a bright-field confocal micrograph on the fluorescence
 image from 6. (Scale bars: 20 um.) P1f COP; P2f PSU.
 Finally, we demonstrate a unique feature of our polymer
 particle fabrication strategy that highlights its versatility with
 respect to structural design. By modifying the macroscopic pre-
 form structure, we produce a unique particle geometry that
 enables us to establish microencapsulation of biological materi-
 als inside a polymeric shell of the same polymer used in the solid
 particles used above in the protein-binding experiments. We use
 collagen as the encapsulant, which may be useful for cosmetics
 and dental applications (58, 59) and serves as a model for other
 potential biological materials or drugs. Like many biological
 materials, collagen is a globular solution lacking uniform fluid
 consistency, and is thus incompatible with fiber drawing and
 traditional microfluidics-based multiple-emulsion approaches.
 We obviate this limitation by injecting the desired encapsulant
 inside a drawn hollow fiber in which a COP layer lines the PSU
 cladding (Fig. 5A and Supporting Information). We inject colla-
 gen into the 50-^m-diameter hollow core (Fig. 5 C) and thermally
 induce the PRI, which results in the core breaking up into
 a necklace of collagen-filled COP microcapsules (Fig. 5 D) held
 stationary in the PSU cladding, which are then released using
 DMAC (Fig. 5 E). We confirm that the microcapsules contain
 protein by dissolving the COP shell (Fig. 5 F) and then using
 a Coomassie Brilliant Blue dye Bradford protein-binding assay
 (60) with the recovered cargo (Supporting Information).
 The two modalities discussed thus far, surface functionaliza-
 tion and volume encapsulation, are combined in Fig. 5 G and H,
 where we demonstrate surface binding of FA4 to collagen-filled
 COP microcapsules. In comparison to current encapsulation
 approaches that usually target biodegradable polymeric shells
 (61, 62), our approach enables encapsulation with a wider range
 of polymers, in addition to access to a broad range of sizes.
 Discussion
 We anticipate that by embedding multiple hollow cores within
 a polymer shell and filling each with different, and potentially in-
 compatible, biological or chemical agents, the PRI-driven breakup
 will produce a polymeric particle that encapsulates these agents in
 isolated enclaves such that the encapsulants do not come into
 contact at any point during the process. Consequently, each par-
 ticle may be considered a multicompartment microreactor that
 produces localized chemical interactions using prescribed ratios of
 reactants upon delivery of the cargo.
 Such size-, material-, and structure-tunable polymeric particles
 fabricated using the scalable, in-fiber, fluid instability-mediated
 process are thus compatible with protein binding and biosensing
 through protein-protein interactions. We expect that this meth-
 odology will have broad applications in developing diagnostic
 tools and cell-specific targeting of biomaterials. In addition, op-
 tical, magnetic, and potentially plasmonic functionalities may be
 embedded within each particle through impregnation of the fiber
 core at the preform level with appropriate dopants. An important
 goal is to extend our methodology to polymers that may be
 processed at lower temperatures to reduce damage or modification
 to encapsulated or impregnated biological materials, thereby pav-
 ing the way to therapeutic applications in drug delivery. Combining
 our results on the precise structuring of multimaterial particles
 using this in-fiber approach (35) with the biomedical capabilities
 described here paves the way for the digital design of a unique class
 of nanoengineered theranostic tools (63), where the chemical,
 hydroscopic, optical, and biomedical properties are all tuned si-
 multaneously within each structured particle through judicious
 design of the macroscopic preform from which the fiber is drawn.
 Materials and Methods
 All the steps and details of the fiber fabrication, particle production, and
 extraction are provided in Supporting Information. Additionally, we give the
 details of surface functionalization and fluorescence measurements. Further
 data on quantifying protein attachment to the particle surfaces is provided.
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